Brendan Hannah
Director of Finance/CFO bij QUINCE THERAPEUTICS, INC.
Vermogen: 213 648 $ op 31-03-2024
Profiel
Brendan Hannah is currently the COO, Chief Financial & Accounting Officer at Quince Therapeutics, Inc. and also holds the position of Chief Operating Officer at Novosteo, Inc. Previously, he worked as the Director of Business Development at Cidara Therapeutics, Inc. and as the Chief Business Officer at Neuroptika, Inc. Mr. Hannah obtained an MBA from the University of California.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-02-2024 | 201 555 ( 0.47% ) | 213 648 $ | 31-03-2024 |
Actieve functies van Brendan Hannah
Bedrijven | Functie | Begin |
---|---|---|
QUINCE THERAPEUTICS, INC. | Director of Finance/CFO | 16-03-2023 |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Chief Operating Officer | - |
Eerdere bekende functies van Brendan Hannah
Bedrijven | Functie | Einde |
---|---|---|
CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2016 |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Opleiding van Brendan Hannah
University of California | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CIDARA THERAPEUTICS, INC. | Health Technology |
QUINCE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |